Delving into the Latest Updates on Huayu Sanjie Tablets with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Eye Diseases

Active Indication

Vitreoretinopathy, Proliferative

Inactive Indication-

Originator Organization

Xi'an Beilin Pharmaceutical Co., Ltd.

Active Organization

Xi'an Beilin Pharmaceutical Co., Ltd.

Inactive Organization-

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

On the basis of routine postoperative treatment, with placebo as control, the optimal dose of Huayu Sanjie Tablets for clinical application was preliminarily explored, and the efficacy and safety of Huayu Sanjie Tablets in the treatment of proliferative vitreoretinopathy with phlegm and blood stasis syndrome after rhegmatogenous retinal detachment reattachment surgery were evaluated.

Start Date-

Sponsor / Collaborator

Xi'an Beilin Pharmaceutical Co., Ltd.

100 Clinical Results associated with Huayu Sanjie Tablets

Login to view more data

100 Translational Medicine associated with Huayu Sanjie Tablets

Login to view more data

100 Patents (Medical) associated with Huayu Sanjie Tablets

Login to view more data

100 Deals associated with Huayu Sanjie Tablets

Login to view more data